相关实验视频
Updated: Jul 12, 2026

08:44
Synthesis and Reaction Chemistry of Nanosize Monosodium Titanate
Published on: February 23, 2016
8.6K
聚多巴胺修改的二氧化纳米管阵列添加作为持续药物输送系统
Lizhong Wu1, Xing Wu1, Linzhao Wu1
1Department of Orthopedics, Fuzhou Second Hospital, Fuzhou, Fujian 350007, China.
ACS omega
|February 5, 2024
概括
这项研究开发了一种新的纳米管 (TNT) 药物递送系统,使用聚多巴胺 (PDA) 和离子 (Ca2+) 进行持续释放. 这种方法增强了药物加载和受控释放,克服了早期突然释放的问题.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 纳米管 (TNT) 阵列是生物相容的药物载体,但患有无法控制的早期药物释放.
- 这限制了它们的治疗时间,并可能导致植入部位的局部毒性.
研究的目的:
- 开发使用TNT的连续药物输送系统,以持续和可控制的药物释放.
- 提高TNT的药物装载能力和释放性能.
主要方法:
- 超声波辅助的聚多巴胺 (PDA) 涂层沉积到TNT上.
- 将离子 (Ca2+) 装载到PDA修饰的TNT中,通过catechol组协调.
- 乙烯酸盐 (NaAL) 药物通过协调键对TNTs-PDA-Ca2+进行共价附着.
主要成果:
- 鉴定证实了成功的PDA涂层和Ca2+结合,增强了TNT的生物活性.
- 观察到改善了药物加载能力和持续释放性能.
- 酸性条件通过Ca2+ - 药物协调键的裂变引发了显著的药物释放.
结论:
- 开发的TNT-PDA-Ca2+-NaAL系统为持续和可控制的药物输送提供了一个有希望的方法.
- 该策略解决了传统TNT载体突然早期药物释放的局限性.
- 该系统的性能表明在局部和长期治疗治疗中有潜在的应用.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

